Medios
About Medios
Medios is a Healthcare company based in Magstadt (Germany), and was acquired by Medios AG in November 2022. Diversified drugs are distributed by Blisterzentrum Baden in Germany. It operates on a Professional Services and B2B2C model. Medios offers products and services including Patient-Specific Blistering and Specialty Pharma Solutions. Its focus areas include Pharmaceuticals and Specialty Pharmaceuticals. Its legal entity is Medios Blister GmbH. Its competitors include CHEPLAPHARM, PHOENIX group and MEDI-MARKT.
Company details
Medios is involved in the provision of specialty pharmaceuticals and patient-specific medication solutions. The company focuses on therapy areas such as oncology, ophthalmology, autoimmunology, neurology, infectiology, and hemophilia. Services include patient-specific blistering of medications, ensuring safety and efficiency in medication management, primarily for pharmacies, nursing homes, and care services. Operations are supported by GMP-compliant production facilities and advanced technology to guarantee reliability and transparency in drug supply.
- Headquarters Magstadt, Germany
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website blisterbw.de
- Social LinkedIn Facebook YouTube
- Acquired by Medios AG (Nov 2022)
- Legal Name Medios Blister Gmbh
Products & Services of Medios
Medios offers a comprehensive portfolio of products and services, including Patient-Specific Blistering and Specialty Pharma Solutions.
Individual medication blistering is provided for patient safety.
Specialized medications are supplied for complex therapy areas.
Apps and channels of Medios
its YouTube channel Medios has 13 subscribers and 2 videos.
Videos from Medios
The most watched videos on Medios's YouTube channel, Medios (13 subscribers). Click a video to play it here.
More on Medios.
Investors in Medios
Medios has secured backing from 1 investor. Prominent investors backing the company include Medios AG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Delivers specialty pharmaceuticals and advanced therapies for healthcare stakeholders. | 2016 | medios.ag | Berlin, Germany |
Investor details for Medios
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Competitors of Medios
Medios has 3 listed competitors in our database. They include CHEPLAPHARM, PHOENIX group and MEDI-MARKT.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cheplapharm.com | 1998 | Mesekenhagen, Germany | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | ||
| phoenixgroup.eu | 1994 | Frankfurt Am Main, Germany | 128 | Leading European provider of pharmaceutical wholesale, retail, and supply chain services. | ||
| medi-markt-profi.de | 1980 | Mannheim, Germany | 275 | Online platform for the procurement of medical equipment |
Detailed competitors of Medios
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medios
Medios is headquartered in Magstadt, Germany. It is registered at Magstadt, Baden-wurttemberg, Germany.
Medios is involved in the provision of specialty pharmaceuticals and patient-specific medication solutions. The company focuses on therapy areas such as oncology, ophthalmology, autoimmunology, neurology, infectiology, and hemophilia. Services include patient-specific blistering of medications, ensuring safety and efficiency in medication management, primarily for pharmacies, nursing homes, and care services. Operations are supported by GMP-compliant production facilities and advanced technology to guarantee reliability and transparency in drug supply.
Medios's top competitors include CHEPLAPHARM, MEDI-MARKT and PHOENIX group.
Medios offers Patient-Specific Blistering and Specialty Pharma Solutions.
Medios has 1 investor. Key investors include Medios AG.
Medios operates through Medios Blister Gmbh.
Yes. Medios was acquired by Medios AG in November 2022.